Histogen Inc (HSTO) Quote

HSTO delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

now thats some STRATEGIC ALTERNATIVE!!!!!!!!!!!!!!!!!!!!!!!

Sep-18-23 04:05PM
Histogen Announces Board Approval of Complete Liquidation and Dissolution
(GlobeNewswire)
Jul-05-23 04:05PM
Histogen to Explore Strategic Alternatives
(GlobeNewswire)

Dissolution news

HSTO new 52 week low

The end, chap11.

Dissolution news = selloff yikes going to be a blood bath

HSTO new 52 week low

HSTO new 52 week low

HSTO new 52 week low

Look at those manipulators steal those shares away from the selling fools.

MM's in mimpulation mode this morning, so they can steal shares from any fool they can get to sell.

Still early

Added HSTO today. Super low float, awesome news, plenty of cash on hand.

That wall seems to have been broken.

Histogen Inc. Obtains US Patent for CTS-2090, an Oral Treatment for Ulcerative Colitis
https://beststocks.com/histogen-inc-obtains-us-patent-for-cts-2090/

Histogen Inc. Obtains US Patent for CTS-2090, an Oral Treatment for Ulcerative Colitis
https://beststocks.com/histogen-inc-obtains-us-patent-for-cts-2090/

$HSTO: Added 10k here at $1.10 !!!!!


Lesssssss gooooooooooooooooooooo


GO $HSTO

As of August 9, 2022, the registrant had 2,497,450 shares of common stock, $0.0001 par value, outstanding.

Huge wall at 2.16 break that and then maybe a larger run

Let’s continue the Friday jog and continue with a sprint on Monday

HSTO stock closed at $2.95 and is up $1.14 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. HSTO has a roughly average overall score of 61 meaning the stock holds a better value than 61% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. HSTO gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Histogen Inc currently has the 130th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders.

UNREAL DUMPING

Nice move today along with nice volume. Would be great to know what caused this action.

TheWhigs

I know someone who is going through a stem cell procedure for a very bad back situation. At this point in time this person is now walking upright and in NO pain.
The doctor who developed this procedure tried to get it through the FDA and could not. My guess is that the FDA being supported by big pharma made sure to protect big PHARMA and the hospitals from losing big money if it was approved. It is a shame the FDA is so corrupt but they are. They have failed many small companies that have Covid products that work but they fail them to protect big Pharma, Ask our past president he knows.

FOR MY PROTECTION -----this is all my opinion

Not a bad quarterly report for a small company sitting on its hands waiting on all kinds of reports and cash to carry them into 3rd qt. As far a reverse split I see no other way for them to get back to meeting NASD qualifications. They could partner with another company or be taken over by another but now that is very highly unlikely in my opinion.

The BOD wants a 1:20 reverse split (I said "NO"). This company is going down the toilet.

HSTO the next bio beast!!!!!

More dilution on the way.

Histogen Announces $3.5 Million Private Placement
8:00 am ET December 16, 2021 (Globe Newswire)

"Histogen Inc. (NASDAQ: HSTO), a clinical-stage company focused on developing potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function, announced today that it has entered into securities purchase agreements with certain institutional and accredited investors to issue, in a private placement, 8,235,297 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 8,235,297 shares of common stock, at a purchase price of $0.425 per share of common stock (or pre-funded warrant) and associated warrant, for expected gross proceeds to Histogen of approximately $3.5 million, before deducting placement agent fees and other offering expenses payable by the Company. The warrants have an exercise price of $0.425 per share of common stock, will be exercisable commencing six months and one day following the date of issuance for a period of five and one-half years from the date of issuance.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the private placement.

The closing of the private placement is expected to occur on or about December 20, 2021, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the private placement for working capital and general corporate purposes."

Yes we are however these penny stocks can move up quickly.

Wtf is going on here ? Sinking like a stone....

Damn we're a long way from 115

$1.15 nice

insightful

.

Something is in the works. This offering doesn’t concern me in the least. We already had cash on hand. Once this closes around the 9th I’m guessing the curtain will be pulled back.

$HSTO

I think we see at least $2.00

Yes sir. Let’s go!

$HSTO

Pop coming soon now. $1.08

Load and hold in this range. Easy swing play from the current pps. Pop inevitable.

$HSTO

Need some love over here....

The sooner the better....

Looking good PM Jimmy.

Shorts are going down. AH will be fun

Added 3k more today. 10 million float. This has to run

This may actually break today. Dang.

They will come soon

Yep were close!

Need this thing to break 1.45 so those short stop losses start hitting and sling shot it to 1.60.. lol

Just need more eyeballs over here....

It wasn't an FDA approval. They just took a hold off the trial. It is still good news but they just missed a sales estimate which people don't take lightly. I still loaded more yesterday at 1.37 though, lol.